A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Betge, Johannes (Author) , Chi-Kern, Jing (Author) , Schulte, Nadine (Author) , Belle, Sebastian (Author) , Gutting, Tobias (Author) , Burgermeister, Elke (Author) , Jesenofsky, Ralf (Author) , Ebert, Matthias (Author) , Härtel, Nicolai (Author)
Format:	Article (Journal)
Language:	English
Published:	London Berlin Heidelberg BioMed Central : Springer 2018 Heidelberg Universitätsbibliothek Heidelberg 2018
DOI:	10.1186/s12885-018-4665-2
Online Access:	Resolving-System, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12885-018-4665-2 Resolving-System, kostenfrei, Volltext: http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-251324
Author Notes:	Johannes Betge; Jing Chi-Kern; Nadine Schulte; Sebastian Belle; Tobias Gutting; Elke Burgermeister; Ralf Jesenofsky; Martin Maenz; Ulrich Wedding; Matthias P. Ebert; Nicolai Haertel

A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax) by Betge, Johannes (Author) , Chi-Kern, Jing (Author) , Schulte, Nadine (Author) , Belle, Sebastian (Author) , Gutting, Tobias (Author) , Burgermeister, Elke (Author) , Jesenofsky, Ralf (Author) , Ebert, Matthias (Author) , Härtel, Nicolai (Author) ,

in: BMC cancer, 18 (2018) Artikel-Nummer 747, 7 Seiten

Article (Journal) Online Resource